PP
PDT Partners Portfolio holdings
AUM
$1.77B
1-Year Return
43.53%
This Quarter Return
+3.39%
1 Year Return
+43.53%
3 Year Return
+141.92%
5 Year Return
+251.03%
10 Year Return
+895.15%
AUM
$661M
AUM Growth
-$473M
(-42%)
Cap. Flow
-$474M
Cap. Flow
% of AUM
-71.66%
Top 10 Holdings %
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358
Top Buys
| 1 |
Coupang
CPNG
|
$3.45M |
| 2 |
AutoZone
AZO
|
$2.98M |
| 3 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$2.7M |
| 4 |
Gartner
IT
|
$2.63M |
| 5 |
Golar LNG
GLNG
|
$2.58M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$7.61M |
| 2 |
General Motors
GM
|
$5.5M |
| 3 |
Qualcomm
QCOM
|
$5M |
| 4 |
US Foods
USFD
|
$4.97M |
| 5 |
Bunge Global
BG
|
$4.77M |
Sector Composition
| 1 | Technology | 21.15% |
| 2 | Healthcare | 20.31% |
| 3 | Financials | 14.07% |
| 4 | Industrials | 12.62% |
| 5 | Consumer Discretionary | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Mine Safety
MSA
$6.67B
| $1.32M | 0.2% |
+12,032
| New | +$1.32M |
|
152
Delek US
DK
$1.87B
| $1.29M | 0.19% |
47,441
-23,803
| -33% | -$646K |
|
153
Heron Therapeutics
HRTX
$199M
| $1.29M | 0.19% |
304,459
-65,475
| -18% | -$276K |
|
|
SPWR
154
DELISTED
SunPower Corporation Common Stock
SPWR
| $1.28M | 0.19% |
55,380
+38,788
| +234% | +$894K |
|
|
NOVA
155
DELISTED
Sunnova Energy
NOVA
| $1.28M | 0.19% |
57,749
-41,762
| -42% | -$922K |
|
156
RLI Corp
RLI
$6.15B
| $1.27M | 0.19% |
24,854
+18,810
| +311% | +$963K |
|
157
Snowflake
SNOW
$74.1B
| $1.27M | 0.19% |
7,459
+2,716
| +57% | +$462K |
|
158
STAAR Surgical
STAA
$1.39B
| $1.26M | 0.19% |
+17,906
| New | +$1.26M |
|
159
BridgeBio Pharma
BBIO
$10.2B
| $1.26M | 0.19% |
+126,293
| New | +$1.26M |
|
160
Cullen/Frost Bankers
CFR
$8.23B
| $1.25M | 0.19% |
9,447
-9,253
| -49% | -$1.22M |
|
|
RVNC
161
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.24M | 0.19% |
45,800
-64,890
| -59% | -$1.75M |
|
162
Genpact
G
$7.82B
| $1.23M | 0.19% |
28,156
-8,596
| -23% | -$376K |
|
163
Aon
AON
$79.9B
| $1.23M | 0.19% |
+4,593
| New | +$1.23M |
|
164
Zoetis
ZTS
$68B
| $1.23M | 0.19% |
8,274
-9,381
| -53% | -$1.39M |
|
165
H.B. Fuller
FUL
$3.33B
| $1.22M | 0.18% |
+20,286
| New | +$1.22M |
|
166
Allogene Therapeutics
ALLO
$255M
| $1.22M | 0.18% |
112,701
-85,018
| -43% | -$918K |
|
167
Range Resources
RRC
$8.2B
| $1.21M | 0.18% |
47,875
+11,475
| +32% | +$290K |
|
168
Viatris
VTRS
$12.2B
| $1.21M | 0.18% |
141,852
-117,110
| -45% | -$998K |
|
169
Century Communities
CCS
$2.06B
| $1.21M | 0.18% |
28,171
-22,139
| -44% | -$947K |
|
170
NewMarket
NEU
$7.67B
| $1.2M | 0.18% |
+3,993
| New | +$1.2M |
|
171
Williams-Sonoma
WSM
$24.5B
| $1.2M | 0.18% |
20,334
-11,068
| -35% | -$652K |
|
|
PDCE
172
DELISTED
PDC Energy, Inc.
PDCE
| $1.2M | 0.18% |
20,703
-45,018
| -68% | -$2.6M |
|
|
BPMC
173
DELISTED
Blueprint Medicines
BPMC
| $1.18M | 0.18% |
+17,948
| New | +$1.18M |
|
174
FIGS
FIGS
$1.1B
| $1.18M | 0.18% |
142,660
-116,793
| -45% | -$964K |
|
175
Archer Daniels Midland
ADM
$29.9B
| $1.17M | 0.18% |
14,571
-33,542
| -70% | -$2.7M |
|